1. Home
  2. ACGLN vs SCLXW Comparison

ACGLN vs SCLXW Comparison

Compare ACGLN & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACGLN
  • SCLXW
  • Stock Information
  • Founded
  • ACGLN N/A
  • SCLXW N/A
  • Country
  • ACGLN Bermuda
  • SCLXW United States
  • Employees
  • ACGLN 5800
  • SCLXW 113
  • Industry
  • ACGLN Property-Casualty Insurers
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACGLN Finance
  • SCLXW Health Care
  • Exchange
  • ACGLN Nasdaq
  • SCLXW Nasdaq
  • Market Cap
  • ACGLN N/A
  • SCLXW N/A
  • IPO Year
  • ACGLN N/A
  • SCLXW 2021
  • Fundamental
  • Price
  • ACGLN $18.16
  • SCLXW $0.22
  • Analyst Decision
  • ACGLN
  • SCLXW
  • Analyst Count
  • ACGLN 0
  • SCLXW 0
  • Target Price
  • ACGLN N/A
  • SCLXW N/A
  • AVG Volume (30 Days)
  • ACGLN N/A
  • SCLXW N/A
  • Earning Date
  • ACGLN N/A
  • SCLXW N/A
  • Dividend Yield
  • ACGLN N/A
  • SCLXW N/A
  • EPS Growth
  • ACGLN N/A
  • SCLXW N/A
  • EPS
  • ACGLN N/A
  • SCLXW N/A
  • Revenue
  • ACGLN N/A
  • SCLXW N/A
  • Revenue This Year
  • ACGLN N/A
  • SCLXW N/A
  • Revenue Next Year
  • ACGLN N/A
  • SCLXW N/A
  • P/E Ratio
  • ACGLN N/A
  • SCLXW N/A
  • Revenue Growth
  • ACGLN N/A
  • SCLXW N/A
  • 52 Week Low
  • ACGLN N/A
  • SCLXW N/A
  • 52 Week High
  • ACGLN N/A
  • SCLXW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ACGLN 23.59
  • SCLXW N/A
  • Support Level
  • ACGLN $17.56
  • SCLXW N/A
  • Resistance Level
  • ACGLN $19.53
  • SCLXW N/A
  • Average True Range (ATR)
  • ACGLN 0.32
  • SCLXW 0.00
  • MACD
  • ACGLN -0.12
  • SCLXW 0.00
  • Stochastic Oscillator
  • ACGLN 28.36
  • SCLXW 0.00

About ACGLN Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: